Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Oligometastatic Prostate Cancer × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 842 Neoplasms 647 Carcinoma, Non-Small-Cell Lung 633 Prostatic Neoplasms 515 Colorectal Neoplasms 415 Lung Neoplasms 380 Neoplasm Metastasis 326 Multiple Myeloma 305 Leukemia, Myeloid, Acute 301 Ovarian Neoplasms 280 Melanoma 255 Squamous Cell Carcinoma of Head and Neck 226 Pancreatic Neoplasms 222 Recurrence 207 Brain Neoplasms 185 Glioblastoma 181 Stomach Neoplasms 175 Carcinoma, Hepatocellular 175 Triple Negative Breast Neoplasms 174 Endometrial Neoplasms 168 Uterine Cervical Neoplasms 167 Lymphoma 163 Precursor Cell Lymphoblastic Leukemia-Lymphoma 159 Head and Neck Neoplasms 154 Carcinoma, Renal Cell 151 Urinary Bladder Neoplasms 142 Leukemia, Lymphocytic, Chronic, B-Cell 138 Lymphoma, Non-Hodgkin 135 Lymphoma, Large B-Cell, Diffuse 132 Glioma 131

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04610372 2026-02-02

PROMPT

British Columbia Cancer Agency

Phase NA Recruiting

Oligometastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡